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a  b  s  t  r  a  c  t
INTRODUCTION:  Wunderlich  syndrome  (WS)  is  a surgical  emergency  characterized  by  spontaneous,  non-
traumatic  retroperitoneal  hemorrhage.  Angiomyolipoma  (AML),  a  benign  mesenchymal  tumor,  is  the
most frequent  cause  of  WS. We  present  a case  of WS,  appearance  ﬁve  days  after  a  left hemicolectomy  for
cancer.
PRESENTATION  OF  CASE:  A  66 years-old  man  with  a sigmoid  adenocarcinoma  and a  small  left  AML  (3.4 cm)
was undergone  to left  hemicolectomy.  He  was  subjected  to bridging  therapy  with  high  doses  of  low-
molecular-weight  heparin  for  prosthetic  replacement  of  heart  valve  secondary  to  endocarditis  and  atrial
ﬁbrillation.  Five  days  after  surgery  he  presents  retroperitoneal  hemorrhage  due  to  rupture  of AML  diag-
nosed by a CT  scan  and  scintigraphy  with  labeled  red  blood  cells.  Total  left nephrectomy  was  performed
as  the  patient  became  unstable.
DISCUSSION:  Rupture  of  a renal  AML is  the  main  cause  of WS.  This  risk  increases  with  the size  of  the
tumor  (>4  cm)  and during  pregnancy.  CT scan is the best  imaging  modalities  for diagnosis.  The  bridging
therapy  increases  the  perioperative  bleeding  risk.  These  patients  are  conservative  treated  with  selective
transarterial  embolization.  Nephrectomy  is  limited  for the  patients  hemodynamically  unstable  or  in case
of failed  embolization.
CONCLUSION:  This  is  a unusual  case  of WS  after surgery  in  patients  with  small  AML  and  treated  with  high
dose of  anticoagulant  for cardiac  disease.  There  are  no  other  similar  cases  in  literature.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Wunderlich syndrome (WS) is a surgical emergency character-
zed by spontaneous, non-traumatic retroperitoneal hemorrhage.
ts symptoms vary from mild to very severe. Renal Angiomyolipoma
AML), a benign mesenchymal tumor, is the most frequent cause of
S [1]. The incidence of this tumor is 0.3–3% with a female to male
ender ratio 4.5:1, it is estimated that ten million people world-
ide have such lesion [2–3]. We  present a case of WS,  appearance
ve days after a left hemicolectomy for cancer.∗ Corresponding author.
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raccio.bartolomeo@email.it (B. Braccio), ninopezze@gmail.com (M. Pezzella),
maliarosariarita.rossetti@gmail.com (A.R.R. Rossetti), francesco.torelli@unina2.it
F. Torelli), giuseppe.izzo@unina2.it (G. Izzo), roberto.alfano@unina2.it (R. Alfano),
atale.dimartino@unina2.it (N. Di Martino).
ttp://dx.doi.org/10.1016/j.ijscr.2015.09.007
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Assoc
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Presentation of case
2.1. Background and past medical history
A 66-years-old Caucasian man  presented to our department
for an Adenocarcinoma of the sigmoid colon associated with an
asymptomatic small left renal Angiomyolipoma (3.4 cm)  diagnosed
accidentally by preoperative CT. About ﬁfteen years before, the
patient was subjected to mitral valvuloplasty with implantation
of prosthetic annulus for ruptured of chordae tendineae; two  years
later he was  reoperated for a staphylococcal endocarditis on pros-
thetic annulus of mitral valve. A preoperative echocardiography
showed an atrial ﬁbrillation with ejection fraction of 55% and mod-
erate aortic regurgitation; for his high thrombo-embolic risk (based
on CHADS2 VASc score) he was  under warfarin treatment.
2.2. Procedure and complicationWarfarin treatment was stopped ﬁve days before the operation
and a bridging anticoagulation therapy, with low-molecular-
weight heparin (enoxaparin 6000UI × 2/die), was introduced. The
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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uig. 1. Computer tomography (CT) scan of abdomen and pelvis, showing a 
nd  thickening of the front and rear renal fascia.
ast dose was given 24 h before the procedure and at this time the
nternational Normalized Ratio (INR) value was 1.3 with platelet
ount of 295.000. Therefore, he was undergone to left hemicolec-
omy, performed without difﬁculty and the day after he restarted
he bridging therapy; the ﬁrst four postoperative days were reg-
lar. Only on the ﬁfth postoperative day, the patient complainedrear renal hematoma (maximum diameter of 7 cm) with perirenal diffusion
pain in the left ﬂank with tachycardia, low blood pressure and olig-
uria. His hemoglobin decreased from 9.2 g/dl to 6.5 g/dl with an
INR value of 1.7 and platelet count of 132.000, and it was nec-
essary a blood transfusion. Computer tomography (CT) scan of
abdomen and pelvis was performed, revealing a large rear renal
hematoma (maximum diameter of 7 cm)  with perirenal diffusion
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nd thickening of the front and rear renal fascia (Fig. 1). For further
valuation, a scintigraphy was made with labeled red blood cells
hat showed an active renal bleeding. These ﬁndings were highly
uggestive of the rupture of the Angiomyolipoma of the left kid-
ey with massive retroperitoneal hemorrhage, a condition known
s Wunderlich syndrome. Clariﬁed the clinical picture and due to
orsening of the symptoms a total emergency nephrectomy was
arried out. Histological examination conﬁrmed the AML  and the
igns of renal and perirenal hematoma. After nephrectomy, the
atient was transferred to intensive care where unfortunately died
0 days after for cardiac complications.
. Discussion
The spontaneous retroperitoneal hemorrhage was  ﬁrst
escribed by Carl Reinhold August Wunderlich, a German
hysician, in 1856. The Lenk’s triad, characterized by ﬂank pain,
bdominal tenderness and signs of internal bleeding, is usually
ssociated with this syndrome [1,4,5]. Several causes are involved,
ncluding benign and malignant renal neoplasm, vascular disease
vasculitis, arteriosclerosis, renal artery aneurism rupture), renal
nfection, undiagnosed hematological desease, renal cysts, antico-
gulant therapy [4,5]. The most frequent cause of WS  is the AML,
 solid “triphasic” tumor composed of varying amounts of three
lements: dismorﬁc blood vessels, smooth muscle components
nd mature adipose tissue [6]; today it is considered among the
amily of perivascular epithelioid cell tumors (PEComa) [7]. While
0% of AMLs are sporadic and approximately 20% are associated
ith tuberous sclerosis complex, in this cohort the tumors are
sually small, multiple and bilateral [8]. The CT scan is a good
hoice of imaging modalities, because it is sensitive to demonstrate
he fat contained in the renal mass with the presence of perirenal
nd retroperitoneal hemorrhage, which is characteristic of Wun-
erlich’s syndrome due to spontaneous angiomyolipoma rupture
9]. The frequency of symptoms and risk of bleeding increase with
he size of the AML. The lesions <4 cm have a 13% risk of bleeding
ersus a 51% risk if >4 cm.  The asymptomatic patients are managed
onservatively with annual CTs (tumors <4 cm)  or semester CTs
>4 cm). There are documented evidences that 27% of lesions
maller than 4 cm and 46% of lesions bigger have been shown to
row up to 4 cm for year over a mean follow up period of 4 years
2]. Other authors have classiﬁed AMLs larger than 4 cm into three
roups based on their vascularity at angiography: (1) minimal
ascularity characterized by few, small and stretched pathological
essels, (2) moderate vascularity with abundant, medium size,
ortuous vessels with or without small aneurysms <5 mm,  (3)
arked vascularity as having multiple, large tortuous vessels
ith or without large aneurysms >5 mm.  AMLs larger than 4 cm
ith “minimal vascularity”, was signiﬁcantly less likely to require
ntervention due to bleeding (14.3%) than those with “marked
ascularity” (50%) [10]. Another factor that increases the risk of
upture of AML  is pregnancy; the main causes are increased grow
ate, blood volume ad renal blood ﬂow. The greater growth during
regnancy, the predominance in women in childbearing age and
he rarity before puberty suggest clear hormone dependence [11].
he symptomatic patients generally have tumours of >8 cm,  these
atients are treated by angiography with selective transarterial
mbolization as ﬁrst line, because of their high risk of spontaneous
r traumatic rupture and consequent retroperitoneal hemorrhage.
n most of the cases of ruptured AML  nephrectomy was done by
pen surgery [1]. Nephrectomy, partial or radical is limited to
emodynamically unstable patients, suspicion of malignancy or
ailed embolization [3]. In our case, according to the size, the AML
as at low risk of bleeding; so, we have hypothesized that the
ow-molecular-weight heparin has played an important role inPEN  ACCESS
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tumor rupture. As already said anticoagulant therapy is one of the
causes of WS  [5]. However, to date there are no evidences for a
direct correlation between anticoagulant therapy and rupture of
a small AML. “The BRIDGE trial” is a recent randomized, double
blind, placebo-controlled trial. It shows that for patients with
atrial ﬁbrillation who require temporary interruption of warfarin
treatment for an elective operation or other elective invasive
procedure, a strategy of forgoing bridging anticoagulation was
non inferior to perioperative bridging with low-molecular-weight
heparin for the prevention of arterial thromboembolism [12]. The
strategy of forgoing to the bridging treatment also decreased the
risk of major bleeding [12]. Thus, was  the bridging therapy appro-
priate to our patient? We  think yes, because patients undergoing
to major surgical procedures (as a left hemicolectomy for cancer)
were not represented in the “BRIDGE trial”, as well as, patients
with mechanical heart valves were speciﬁcally not included.
Another study, focused on predictors of major bleeding events
(MBEs) in patients with mechanical heart valves (MHV) under-
going invasive procedures, with periprocedural bridging with
low-molecular-weight heparin (LMWH), shows that the bleeding
risk is independent to LMWH  dose and the major predictor for MBE
is the bleeding risk of the surgery [13]. It shows that the bleeding
risk is independent from LMWH  dose and the major predictor for
MBEs is the bleeding risk of the surgery [13].
4. Conclusion
We have reported a rare case of WS  due to rupture of small
AML  occurred ﬁve days after a left hemicolectomy for cancer. The
bleeding of AML  <4 cm is a very rare event but is a potentially life
threatening condition. In our case surgery is been mandatory, so, we
have carried out a nephrectomy because the patient became hemo-
dynamically unstable. In conclusion, we suppose that the breaking
of the lesion is been favored by bridging therapy with LMWH,  but
we cannot know well the determining causes because there are no
other cases in literature of AML’s rupture after colo-rectal surgery.
Moreover, we know that the bridging therapy increases the periop-
erative bleeding risk, regardless of LMWH  dose, but in correlation
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